Vertigo and motion sickness. Part I: Vestibular anatomy and physiology

Ear, Nose and Throat Journal

Volumn 84, Issue 9, 2005, Pages 581-584

  Zajonc, Timothy P ^a   Roland, Peter S ^b  

^a ENT Associates   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMPA RECEPTOR; BETA ADRENERGIC RECEPTOR; DOPAMINE RECEPTOR; HISTAMINE RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SEROTONIN RECEPTOR;

AREA POSTREMA; BRAIN CORTEX; CEREBELLUM; HUMAN; MOTION SICKNESS; NEUROPHYSIOLOGY; REVIEW; VERTIGO; VESTIBULAR NUCLEUS; VESTIBULAR SYSTEM; VOMITING; BIOLOGICAL MODEL; HISTOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VESTIBULE;

AREA POSTREMA; CEREBELLUM; HUMANS; MODELS, BIOLOGICAL; MOTION SICKNESS; VERTIGO; VESTIBULE; VOMITING;

EID: 33644846704     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130508400912     Document Type: Review

References (37)

1. Crampton GH, ed. Motion and Space Sickness. Boca Raton, Fla.: CRC Press, 1990.
2. Raymond J, Nieoullon A, Dememes D, Sans A. Evidence for glutamate as a neurotransmitter in the cat vestibular nerve: Radioautographic and biochemical studies. Exp Brain Res 1984;56:523-31.
3. Gallagher JP. An electrophysiological investigation of the rat medial vestibular nucleus in vitro. In: Correia MJ, Perachio AA, eds. Contemporary Sensory Neurobiology. (Proceedings of the third symposium of the Galveston chapter of the Society for Neuroscience; May 14-15, 1984; Galveston, Tex.) New York: Alan R. Liss, 1985:293.
4. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: An update. Brain Res Bull 1998;47:395-406.
5. Matsuoka I, Domino EF. Cholinergic mechanisms in the cat vestibular system. Neuropharmacology 1975;14:201-10.
6. Matsuoka I, Ito J, Takahashi H, et al. Experimental vestibular pharmacology: A minireview with special reference to neuroactive substances and antivertigo drugs. Acta Otolaryngol Suppl 1984;419:62-70.
7. Weiner DM, Brann MR. The distribution of a dopamine D2 receptor mRNA in rat brain. FEBS Lett 1989;253:207-13.
8. Hulme EC, Birdsall NJ, Buckley NJ. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990;30:633-73.
9. Pedigo NW, Jr, Brizzee KR. Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis. Brain Res Bull 1985;14:169-77.
10. Lewis MR. Histamine H1 and H2 mechanisms may modulate motion sickness development. Aerospace Medical Association Abstract 1987:A10.
11. Takatani T, Ito J, Matsuoka I, et al. Effects of diphenhydramine iontophoretically applied onto neurons in the medial and lateral vestibular nuclei. Jpn J Pharmacol 1983;33:557-61. 7
12. Otsuka M, Yanagisawa M. Does substance P act as a pain transmitter? Trends Pharraacol Sci 1987;8:506-10.
13. deWaele C, Muhlethaler M, Vidal PP. Neurochemistry of the central vestibular pathways. Brain Res Brain Res Rev 1995;20:24-46.
14. Zanni M, Giardino L, Toschi L, et al. Distribution of neurotransmitters, neuropeptides, and receptors in the vestibular nuclei complex of the rat. An immunocytochemical, in situ hybridization and quantitative receptor autoradiographic study. Brain Res Bull 1995;36:443-52.
15. Kirsten EB, Sharma JN. Characteristics and response differences to iontophoretically applied norepinephrine, D-amphetamine, and acety lcholine on neurons in the medial and lateral vestibular nuclei of the cat. Brain Res 1976;112:77-90.
16. Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science. 3rd ed. New York: Elsevier, 1991.
17. Robinson DA. Adaptive gain control of vestibuloocular reflex by the cerebellum. J Neurophysiol 1976;39:954-69.
18. Singleton GT. Relationships of the cerebellar nodulus to vestibular function: A study of the effects of nodulectomy on habituation. Laryngoscope 1967;77:1579-1619.
19. Tyler DB, Bard P. Motion sickness. Physiol Rev 1949;29:311-69.
20. Ito M. Recent advances in cerebellar physiology and pathology. Adv Neurol 1978;21:59-84.
21. Llinas R, Walton K, Hillman DE, Sotelo C. Inferior olive: Its role in motor learning. Science 1975;190:1230-1.
22. Borison HL, Wang SC. Functional localization of central coordinating mechanism for emesis in cat. J Neurophysiol 1949;12:305-13.
23. Hasegawa S, Takeda N, Morita M, et al. Vestibular, central and gastral triggering of emesis: A study on individual susceptibility in rats. Acta Otolaryngol 1992;112:927-31.
24. Baloh RW. Dizziness, Hearing Loss, and Tinnitus. Philadelphia: EA. Davis, 1998.
25. Palermo-Neto J. Dopaminergic systems. Dopaminergic receptors. Psychiatr Clin North Am 1997;20:705-21.
26. Missale C, Nash SR, Robinson SW, et al. Dopamine receptors: From structure to function. Physiol Rev 1998;78:189-225.
27. Jaarsma D, Ruigrok TJ, Caffe R, et al. Cholinergic innervation and receptors in the cerebellum. Prog Brain Res 1997;114:67-96.
28. Russo-Neustadt A, Cotman CW. Adrenergic receptors in Alzheimer's disease brain: Selective increases in the cerebella of aggressive patients. J Neurosci 1997;17:5573-80.
29. Pompeiano O. Noradrenergic influences on the cerebellar cortex: Effects on vestibular reflexes under basic and adaptive conditions. Otolaryngol Head Neck Surg 1998;119:93-105.
30. Bongianni F, Mutolo D, Carfi M, Pantaleo T. Area postrema glutamate receptors mediate respiratory and gastric responses in the rabbit. Neuroreport 1998;9:2057-62.
31. Cumming P, Gjedde A, Vincent S. Histamine H3 binding sites in rat brain: Localization in the nucleus of the solitary tract. Brain Res 1994;641:198-202.
32. Qian M, Johnson AE, Kallstrom L, et al. Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: Possible relationship to ingestive behavior. Neuroscience 1997;77:1077-89.
33. Hyde TM, Knable MB, Murray AM. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 1996;24:224-32.
34. Yoshikawa T, Yoshida N, Hosoki K. Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. Eur J Pharmacol 1996;301:143-9.
35. Paakkari I, Karppanen H, Paakkari P. Site and mode of action of clonidine in the central nervous system. Acta Med Scand Suppl 1976;602:106-9.
36. Avoli M, Hwa G, Louvel J, et al. Functional and pharmacological properties of GABA-mediated inhibition in the human neocortex. Can J Physiol Pharmacol 1997;75:526-34.
37. Yabe T, de Waele C, Serafin M, et al. Medial vestibular nucleus in the guinea-pig: Histaminergic receptors. II. An in vitro study. Exp Brain Res 1993;93:249-58.